Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29,881,634
-
Total 13F shares
-
8,722,358
-
Share change
-
-593
-
Total reported value
-
$127,589,352
-
Put/Call ratio
-
75%
-
Price per share
-
$14.64
-
Number of holders
-
46
-
Value change
-
-$1,309,423
-
Number of buys
-
23
-
Number of sells
-
20
Institutional Holders of Profound Medical Corp. - Common Shares (PROF) as of Q3 2021
As of 30 Sep 2021 Profound Medical Corp. - Common Shares (PROF) had 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,722,358 shares of stock of the company.
Largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FIL Ltd, GAGNON SECURITIES LLC, LETKO, BROSSEAU & ASSOCIATES INC, Redmile Group, LLC, Blackcrane Capital, LLC, ROYCE & ASSOCIATES LP, Gagnon Advisors, LLC, AWM Investment Company, Inc., and ROYAL BANK OF CANADA.
This table shows 46 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.